Journal Information
Vol. 57. Issue 5.
Pages 391-393 (1 November 2002)
Vol. 57. Issue 5.
Pages 391-393 (1 November 2002)
Full text access
Impacto de la infección neumocócica invasora en niños
Visits
7721
X. Sáez-Llorens
Corresponding author
xsaezll@cwpanama.net

Correspondencia: Prof. X. Sáez-Llorens.
Profesor de Pediatría y Jefe de Infectología. Universidad de Panamá. Hospital del Niño
This item has received
Article information
Full text is only available in PDF
Bibliografía
[1.]
American Academy of Pediatrics. Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
Pediatrics, 106 (2000), pp. 362-366
[2.]
W. Watson.
Pneumococcal conjugate vaccines.
Pediatr Infect Dis J, 19 (2000), pp. 331-332
[3.]
R. Dagan, R. Melamed, O. Zamir, O. Leroy.
Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B,14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their booster ability by native polysaccharide antigens.
Pediatr Infect Dis J, 16 (1997), pp. 1053-1059
[4.]
H.R. Shinefield, S. Black, P. Ray, I. Chang, N. Lewis, B. Fireman, et al.
Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
Pediatr Infect Dis J, 18 (1999), pp. 757-763
[5.]
S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, J.R. Hansen, et al.
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.
Pediatr Infect Dis J, 19 (2000), pp. 187-195
[6.]
J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, E. Herva, et al.
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.
N Engl J Med, 334 (2001), pp. 403-409
Copyright © 2002. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools